SCHEMBL1148154

SCHEMBL1148154

CCOc1ccc(OC(C)(C(=O)OC)C(=O)OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ PLK1 P53350 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ NQO1 P15559 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.47
▸ PARP10 Q53GL7 1/20 0.47
▸ TSHR P16473 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ EPHX2 P34913 1/20 0.44
▸ NR1H4 Q96RI1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1148349 0.82 NQO1 (0.52) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL16573638 0.79 PLK1 (0.53) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL28275183 0.79 PLK1 (0.53) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL1148193 0.79 KMT2A (0.49) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL1148156 0.79 TSHR (0.51) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL1148153 0.77 ALDH1A1 (0.49) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL16173538 0.76 PLK1 (0.46) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL9475726 0.75 PLK1 (0.51) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL9588418 0.74 CYP1A2 (0.53) POLBTDP1CYP1A2PLK1MEN1
SCHEMBL9476412 0.73 PLK1 (0.50) POLBTDP1CYP1A2PLK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884103-B2 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi SYNGENTA CROP PROTECTION, INC. (US) 2011-02-08 — — US disclosed
US-20070155748-A1 N-sulfonyl-alpha-amino-acid derivatives SYNGENTA CROP PROTECTION, INC. 2007-07-05 — — US disclosed
EP-1660441-A2 N-SULFONYL-ALPHA-AMINO-ACID DERIVATIVES Syngenta Participations AG (CH) 2006-05-31 — — EP disclosed
WO-2005021490-A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2005-03-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155748-A1 N-sulfonyl-alpha-amino-acid derivatives C3AR1, GLRA1, C5AR1 POLB 4770/4885TDP1 4650/4885CYP1A2 838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback